1. Home
  2. FNWD vs EPRX Comparison

FNWD vs EPRX Comparison

Compare FNWD & EPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FNWD
  • EPRX
  • Stock Information
  • Founded
  • FNWD 1994
  • EPRX 2011
  • Country
  • FNWD United States
  • EPRX Canada
  • Employees
  • FNWD N/A
  • EPRX N/A
  • Industry
  • FNWD Savings Institutions
  • EPRX
  • Sector
  • FNWD Finance
  • EPRX
  • Exchange
  • FNWD Nasdaq
  • EPRX NYSE
  • Market Cap
  • FNWD 121.8M
  • EPRX 137.7M
  • IPO Year
  • FNWD N/A
  • EPRX N/A
  • Fundamental
  • Price
  • FNWD $27.70
  • EPRX $5.49
  • Analyst Decision
  • FNWD Buy
  • EPRX Strong Buy
  • Analyst Count
  • FNWD 1
  • EPRX 2
  • Target Price
  • FNWD $34.00
  • EPRX $11.50
  • AVG Volume (30 Days)
  • FNWD 44.4K
  • EPRX 12.9K
  • Earning Date
  • FNWD 08-05-2025
  • EPRX 08-07-2025
  • Dividend Yield
  • FNWD 1.73%
  • EPRX N/A
  • EPS Growth
  • FNWD N/A
  • EPRX N/A
  • EPS
  • FNWD 0.78
  • EPRX N/A
  • Revenue
  • FNWD $61,430,000.00
  • EPRX N/A
  • Revenue This Year
  • FNWD N/A
  • EPRX N/A
  • Revenue Next Year
  • FNWD $6.97
  • EPRX N/A
  • P/E Ratio
  • FNWD $35.71
  • EPRX N/A
  • Revenue Growth
  • FNWD N/A
  • EPRX N/A
  • 52 Week Low
  • FNWD $26.12
  • EPRX $2.20
  • 52 Week High
  • FNWD $33.50
  • EPRX $6.20
  • Technical
  • Relative Strength Index (RSI)
  • FNWD 49.11
  • EPRX N/A
  • Support Level
  • FNWD $26.70
  • EPRX N/A
  • Resistance Level
  • FNWD $28.50
  • EPRX N/A
  • Average True Range (ATR)
  • FNWD 0.67
  • EPRX 0.00
  • MACD
  • FNWD 0.07
  • EPRX 0.00
  • Stochastic Oscillator
  • FNWD 60.78
  • EPRX 0.00

About FNWD Finward Bancorp

Finward Bancorp is a bank holding company, which engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Saving Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out through the United States.

About EPRX EUPRAXIA PHARMACEUTICALS INC

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with unmet medical needs.

Share on Social Networks: